Hawaii HB562 prohibits 340B covered entities from entering into contracts that limit use of contract pharmacies.
Hawaii HB562 aims to protect the integrity of the 340B drug pricing program by prohibiting covered entities from entering into contracts that restrict the use of contract pharmacies. This bill also voids contract provisions based on the maximum allowable cost payment model and authorizes the attorney general to bring civil actions for violations. The 340B program is crucial for providing low-income and uninsured populations with access to healthcare and medications, and it allows hospitals to reinvest savings into essential community benefits.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.